Physician

Sanjay Chamanlal Dhar, MD

According to 2025 Medicare claims, Sanjay Dhar, MD (NPI: 1811074586) practices cardiology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is PROVIDENCE MEDICAL FOUNDATION (NPI: 1740584473; TIN: 330185031) and primary practice location at 95405-4555. Dhar is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), participating under the MSSP model.

Dhar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,850 traditional Medicare patients, billed 10,755 HCPCS/CPT codes, and received $702,428 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 11,884 prescription claims across 1,422 beneficiaries totaling $6,414,798 in drug costs, led by Vyndamax (Tafamidis). 2019 DME data shows 12 claims. Open Payments data shows 117 records totaling $3,705. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $532,532 to $6,414,798. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $47,740 to $1,230.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,695	10,112	$614,476
2016	1,949	10,123	$670,870
2017	2,075	10,029	$682,172
2018	2,212	10,942	$727,376
2019	2,103	9,904	$692,068
2020	2,135	8,617	$580,914
2021	2,310	8,449	$648,644
2022	2,459	9,302	$698,635
2023	2,684	9,653	$700,711
2024	2,850	10,755	$702,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	709	7,574	$532,532
2016	784	8,223	$874,826
2017	849	8,510	$1,133,311
2018	929	7,964	$1,416,375
2019	1,010	8,570	$1,738,244
2020	1,062	8,971	$2,174,112
2021	1,114	9,439	$2,399,924
2022	1,203	9,689	$3,417,549
2023	1,232	10,136	$4,255,658
2024	1,422	11,884	$6,414,798

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	117	$46,891
2016	N/R	41	$3,125
2017	N/R	11	$129,280
2018	N/R	N/R	N/R
2019	N/R	12	$649
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,157	1,225	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,240	1,810	$99
75571	Ct scan of heart with evaluation of blood vessel calcium	470	470	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	506	687	$73
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	711	788	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	97	3,390	$2,612,572
Eliquis	Apixaban	1,079	67,492	$1,298,863
Entresto	Sacubitril/Valsartan	436	25,509	$513,537
Xarelto	Rivaroxaban	362	22,640	$409,486
Vyndaqel	Tafamidis Meglumine	12	360	$268,066

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	117	$3,705	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sanjay Chamanlal Dhar, MD?

Tedicare shows public-source Medicare data for Sanjay Chamanlal Dhar, MD (NPI 1811074586), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sanjay Chamanlal Dhar, MD have ACO affiliation data?

Sanjay Chamanlal Dhar, MD is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342).

What billing organization is linked to Sanjay Chamanlal Dhar, MD?

Sanjay Chamanlal Dhar, MD is linked to PROVIDENCE MEDICAL FOUNDATION (billing NPI 1740584473) in the available physician profile data.

Does Sanjay Chamanlal Dhar, MD have Open Payments data?

Sanjay Chamanlal Dhar, MD has 117 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.